 Home > Medical News >

Medical Research Articles

Foamix medium to severe acne minocycline foam preparation FMX1013 clinical study gets positive top-line results

 Time of Update: 2020-06-11

1 2 ghz cyclobenzaprine drug test 12 3 mc 6.2 divided 1 2 iodine phase diagram

acne is a chronic inflammatory skin disease that often occurs in the skin lipid glands and hair follicles, and the symptoms are divided into inflammatory (papules and abscesses) and non-inflammatory
Bollinger Ingel-Hengham-Hehua ® can be ® approved by the China Drug Administration

 Time of Update: 2020-06-11

ammonia inhalation treatment beta galactosidase function levemir long acting d2 receptor function alpha 2 receptor agonist

recently Bollinger Ingham announced that the ® of siphonsofler ® (Pyro Brominamon/Odatro Inhalation Spray) has been officially approved by the China Drug (Supervisory Authority for long-term maint
TWO CLINICAL PROOF-OF-CONCEPT TRIALS OF BLU-667 AND OSIMERTINIB IN COMBINATION WITH THE TREATMENT OF NSCLC RESULTED IN POSITIVE RESULTS

 Time of Update: 2020-06-11

graviola cancer checkers 2 5 breast cancer metastasis lung pd 1 therapy cancer research news

Today, Blueprint Medicines at the World Lung Cancer Conference organized by the International Association for Lung Cancer Research (at the of the Study of The Study of Specific RET Receptor Inhib
FDA Grants MEK Inhibitor PD-0325901 For Orphan Drug Treatment of Neurofibromatosis Type 1

 Time of Update: 2020-06-11

a hair 1 2 butadiene pfizer drugs 1 2 ghz herpes 1 2

type 1 neurofibromatosis (NF1) is a rare genetic disease caused by mutations in the NF1 gene that can affect children and adults recently, SpringWorks ( FDA has granted MEK inhibitor PD-0325901
FDA approves Onpattro infusion therapy for adult patients with peripheral neurological disorders

 Time of Update: 2020-06-11

daily temperature chart nattokinase blood pressure brain heart infusion fda drug classification body detoxing symptoms

recently, the U.S FDA (announced the approval of Onpattro (patisiran) infusion therapy for adult patients with peripheral neuropathy (polyneuropathy) caused by hereditary thyroxine amyloid degener
Treasure Island Pharmaceuticals Class 1 anti-cancer drug HZB1006 capsule registration application accepted by the State Drug Administration

 Time of Update: 2020-06-11

advanced innovative technology bubble drug abilify drug pink new drug xarelto drug class

recently, Heilongjiang Treasure Island Pharmaceuticals announced that its sub- company (Harbin Treasure Pharmaceutical (research and development of 1 class of anti-cancer new drug (capsule reg
Cardiovascular new drug Vascepa outcome trial REDUCE-IT reaches its main endpoint and multiple secondary endpoints

 Time of Update: 2020-06-11

iso 32 oil reduce cholesterol supplements new wave omega 3 fatty acids fish oil omega 3 inflammation

recently, Amarin Corporation announced the vassapent cardiovascular (CV) cardiovascular outcome the of the trial( the main results of which reached its main endpoint and multiple secondary endpoin
NMPA accepts application for new drug listing of Cinda Bio in research drug Adamu mono-anti-injection biosimilars

 Time of Update: 2020-06-11

amino acid chain brain tumor classification amino acid letters therapeutic monoclonal antibodies drug injection

today, Cinda Bio Pharmaceutical (HKSE Code: 1801) announced that the National Pharmaceutical (NMPA) has accepted the new drug (NDA) of the Pharmaceutical (Adamu mono-injectable biosimilars)
New drug meavert can prevent the growth and spread of pancreatic cancer, study says

 Time of Update: 2020-06-11

cancer peritoneal metastasis fungal breast cancer immunotherapy cancer drugs growth bht cancer

pancreatic cancer, one of the leading causes of cancer-related death in the United States, poses a significant threat to the public's health This year, about 55,000 people in the U.S will be diagn
FDA approves expansion of Humira's treatment of non-infectious vyreitis

 Time of Update: 2020-06-11

drug therapy definition data price torix drug sitagliptin drug class enbrel drug

viticulture is a group of eye diseases characterized by inflammation of the vine membrane (including irises, veins, eyelashes) that, if not treated in a timely manner, can seriously damage vision, l
A brief application for a new drug "non-Lotte flat release tablets" declared by the FDA of Ling Pharmaceuticals has been approved

 Time of Update: 2020-06-11

slow release antihypertensive drugs pharmaceutical science jobs drugs used anesthesia products use accutane

recently, Eling Pharmaceuticals announced that the Company (wholly-owned subsidiary Ofling Wanzhou International Pharmaceutical (to the FDA (declared "non-Lotte flat release" new drug (brief
AbbVie's heavy-duty drug Imbruvica and Roche's Rituxan combination therapy get FDA approval

 Time of Update: 2020-06-11

myostatin inhibitor human heavy duty lift zolmitriptan 5 mg found lunesta 2 mg

WM is an extremely rare and currently incurable category of non-Hodgkin's lymphoma (NHL), most commonly found in the bone marrow of older adult patients and may also have an effect on the lymph nodes
FDA approves Zemdri (plazomicin) for treatment of complex urinary tract infections

 Time of Update: 2020-06-11

beta 2 blockers 1 ml dropper ans 1 2 azithromycin broad spectrum beta lactamase test

recently, Achaogen (announcing that the U.S FDA (approved for its Zemdri (plazomicin) for patients with complex urinary tract infections (cUTI) caused by certain E coli infections, including tho
Roche submits application to FDA for new drug in Venclexta

 Time of Update: 2020-06-11

low dose ritalin pd 7 application drug discovery today acute gastroenteritis treatment recovery factor

today, Roche's Genentech announced it had submitted a supplementto- new drug (sNDA) to the FDA if the application is approved, Venclexta may be treated with the primary treatment of acute myelo
AstraZeneca Olapale film has completed review approval for domestic listing application

 Time of Update: 2020-06-11

drug test passer methocarbamol drug test nano 8 review sewage treatment process cyp3a4 inhibitors list

recent days, AstraZeneca (Olaparis), has completed the review and approval of domestic listing applications, is expected to be approved for listing January 2018, AstraZeneca Olapale tablets were
Uber's new drug, Upro® approved for treatment of early isopathic Parkinson's disease symptoms and signs

 Time of Update: 2020-06-11

what expectorant drug propanol drug autoimmune treatment femara drug imodium drug interactions

recently, Usby announced that its new drug (The Uuplo ® obtained the approval of the National Drug (supervisory authority) for single-drug treatment (not associated with levodopa) early isopathi
FDA approves DrugsMD company Bijuva for treatment of vascular movement disorders in menopausal patients

 Time of Update: 2020-06-11

parkinson's treatment drug estrogen progesterone pills amitriptyline 100 mg study hormones bio 100

about 43 million women in the U.S are in menopause, and as the ovaries stop producing estrogen, estrogen levels in the blood circulation drop, leading to VMS, often characterized by hot flashes and
European Commission approves Sanofi nanoantibody drug Cablivi for acquired thrombosis platelet-reducing adult patients

 Time of Update: 2020-06-11

cystex active ingredient libtayo fda approval united states industries pepto active ingredient allegra active ingredient

aTTP is a life-threatening, autoimmune-based clotting disorder characterized by the formation of large numbers of blood clots in small blood vessels throughout the body, leading to severe thrombocyto
FDA approves Sympazan oral membrane for treatment of LGS-related seizures in patients 2 years and older

 Time of Update: 2020-06-11

sucralose brand name ritalin dosage high risperidone brand name docetaxel brand name which type forgery

recently, Aquestive StoveS announced that the U.S FDA approved Sympazan (clobazam, chlorbagen) oral membrane for patients 2 years and older to treat seizures associated with Lennox-Gastaut syndrom
FDA approves Lilly migraine new emgality for preventive treatment of adult migraines

 Time of Update: 2020-06-11

drug panel amyl drug na group number antibody drug conjugate food allergy prevention

recently, the U.S Food and Drug ( FDA ( FDA) has approved Lilly 's new drug (galcanezumab-gnlm) 120mg injection for the prevention of migraines in adults Emgality will provide a monthly, self

Go to Page

Medical Research Articles

Foamix medium to severe acne minocycline foam preparation FMX1013 clinical study gets positive top-line results

Bollinger Ingel-Hengham-Hehua ® can be ® approved by the China Drug Administration

TWO CLINICAL PROOF-OF-CONCEPT TRIALS OF BLU-667 AND OSIMERTINIB IN COMBINATION WITH THE TREATMENT OF NSCLC RESULTED IN POSITIVE RESULTS

FDA Grants MEK Inhibitor PD-0325901 For Orphan Drug Treatment of Neurofibromatosis Type 1

FDA approves Onpattro infusion therapy for adult patients with peripheral neurological disorders

Treasure Island Pharmaceuticals Class 1 anti-cancer drug HZB1006 capsule registration application accepted by the State Drug Administration

Cardiovascular new drug Vascepa outcome trial REDUCE-IT reaches its main endpoint and multiple secondary endpoints

NMPA accepts application for new drug listing of Cinda Bio in research drug Adamu mono-anti-injection biosimilars

New drug meavert can prevent the growth and spread of pancreatic cancer, study says

FDA approves expansion of Humira's treatment of non-infectious vyreitis

A brief application for a new drug "non-Lotte flat release tablets" declared by the FDA of Ling Pharmaceuticals has been approved

AbbVie's heavy-duty drug Imbruvica and Roche's Rituxan combination therapy get FDA approval

FDA approves Zemdri (plazomicin) for treatment of complex urinary tract infections

Roche submits application to FDA for new drug in Venclexta

AstraZeneca Olapale film has completed review approval for domestic listing application

Uber's new drug, Upro® approved for treatment of early isopathic Parkinson's disease symptoms and signs

FDA approves DrugsMD company Bijuva for treatment of vascular movement disorders in menopausal patients

European Commission approves Sanofi nanoantibody drug Cablivi for acquired thrombosis platelet-reducing adult patients

FDA approves Sympazan oral membrane for treatment of LGS-related seizures in patients 2 years and older

FDA approves Lilly migraine new emgality for preventive treatment of adult migraines